MoneyWorks4Me

Combat Drugs informs about revised consolidated financials results

25 Feb 2019 Evaluate

Combat Drugs has informed about Revised Consolidated Financial results for the Quarter ended 31 December 2018.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..